Vasoactive intestinal polypeptide and other preprovasoactive intestinal polypeptide-derived peptides in the female and male genital tract: localization, biosynthesis, and functional and clinical significance.
Vasoactive intestinal polypeptide, a neuropeptide with wide distribution in the central and peripheral nervous system, has a broad spectrum of biologic actions. The demonstration of vasoactive intestinal polypeptide containing nerve fibers within the female and male genital tract 17 years ago indicated a putative role for this peptide in the local nervous control of reproductive functions. The genes encoding the preprovasoactive intestinal polypeptide precursor molecule and the vasoactive intestinal polypeptide receptor have been identified. The gene expression has been studied by the use of specific antibodies against the functional domains of the vasoactive intestinal polypeptide precursor and the biologic action elucidated by both in vivo and in vitro methods. Evidence has been provided to support vasoactive intestinal polypeptide as a neurotransmitter in several physiologic events in the genital tracts (i.e., blood flow and nonvascular smooth muscle relaxation). In the ovary vasoactive intestinal polypeptide seems to play an important role as regulator and/or modulator of folliculogenesis and steroidogenesis. In the male genital tract vasoactive intestinal polypeptide seems to participate in the control of erection. Vasoactive intestinal polypeptide has been suggested as a causative factor in some diseases of the genital organs (e.g., it may play a pathophysiologic role in male impotence and the peptide is currently used in the treatment of this condition). Vasoactive intestinal polypeptide may be important for control of the low resistance in the fetomaternal vascular bed and is therefore a putative factor involved in the development of preeclampsia. The therapeutic potential of vasoactive intestinal polypeptide and future agonists and antagonists will be revealed by ongoing and forthcoming studies.
Ottesen
B
B
Department of Obstetrics and Gynecology, Hvidovre Hospital, University of Copenhagen, Denmark.
Fahrenkrug
J
J
D000595:Amino Acid Sequence; D001143:Arousal; D001665:Binding Sites; D005260:Female; D005836:Genitalia, Female / Q000098:blood supply / Q000378:metabolism* / Q000502:physiology; D005837:Genitalia, Male / Q000098:blood supply / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D018377:Neurotransmitter Agents / Q000502:physiology; D010053:Ovary / Q000502:physiology; D010066:Ovum Transport; D010410:Penile Erection; D011498:Protein Precursors / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*; D012039:Regional Blood Flow; D014590:Uterine Contraction; D014660:Vasoactive Intestinal Peptide / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology*
D018377:Neurotransmitter Agents; D011498:Protein Precursors; D014660:Vasoactive Intestinal Peptide; C055594:preprovasoactive intestinal peptide